Results 41 to 50 of about 2,934 (87)

Recurrent Cytokine Release Syndrome in Metastatic Gastric Cancer on Nivolumab-FOLFOX: A Case Report and Mechanistic Review. [PDF]

J Gastrointest Cancer
Islam J, Rashid Z, Munster AB, Hughes P, Badzek S, Huda I.   +5 more
europepmc   +1 more source

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol. [PDF]

Clin Exp Med
Christodoulis E, Vlachostergios PJ, Connell J, Williams J, Hasan J, Mansoor W, Mullamitha S, Hubner RA, Braun M, Saunders MP, Marti Marti F, Angelakas A, Waddell T, Alam N, Kamposioras K.   +14 more
europepmc   +1 more source

Golden immunity: gold complexes as emerging triggers of immunogenic cell death. [PDF]

Chem Sci
Redrado M, Gimeno MC.
europepmc   +1 more source

Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx). [PDF]

BMC Cancer
Lagenfelt H, Blomstrand H, Gränsmark E, Elander NO.   +3 more
europepmc   +1 more source

Temporal association of diffuse large B-cell lymphoma with PD-1 inhibitor therapy in a patient with gastric adenocarcinoma: a case report. [PDF]

Front Immunol
Jiang Y, Wu K, Hu J, Yu M, Xu Y, Xu Z, Cao R, Zhang Y, Gao Y, Liu S, Ding Y.   +10 more
europepmc   +1 more source

Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study. [PDF]

J Cancer Res Clin Oncol
Li S, Xian B, Cui L, Wu L, Fang C, Yang F, Li J.   +6 more
europepmc   +1 more source

Novel Platinum(II) Tetrazine Complex Capable of Live-Cell IEDDA Reaction. [PDF]

Chembiochem
O'Dowd PD, Wu D, Benny A, King E, Harford A, Twamley B, Piskareva O, O'Shea DF, Griffith DM.   +8 more
europepmc   +1 more source

A case report of insulin autoimmune syndrome induced by drugs for colorectal cancer. [PDF]

Medicine (Baltimore)
Wu X, Bao L, Fan G, Wang S.
europepmc   +1 more source

Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models. [PDF]

J Med Chem
Sharkawy S, Acharya S, Kostrhunová H, Maji M, Marková L, Novohradský V, Gibson D, Brabec V.   +7 more
europepmc   +1 more source

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer. [PDF]

N Engl J Med
Sinicrope FA, Ou FS, Arnold D, Peters WR, Behrens RJ, Lieu CH, Matin K, Cohen DJ, Potter SL, Nixon AB, Kottschade LA, Kathol E, Frankel WL, Shergill A, Hsu D, Reinacher-Schick A, Mehan P, Gold PJ, Khalil MF, Zemla T, Gatten C, O'Reilly EM, Meyerhardt JA.   +22 more
europepmc   +1 more source